The Estonia pharmaceutical market was valued at USD 493.50 Million in 2023, driven by the rising incidence of chronic diseases and government initiatives across the region. The market is anticipated to grow at a CAGR of 6.55% during the forecast period of 2024-2032, with the values likely to reach USD 873.51 Million by 2032.
Base Year
Historical Year
Forecast Year
The pharmaceutical industry involves the development, production, and marketing of medications that improve health outcomes. It spans a wide range of therapeutic areas, including oncology, immunology, cardiology, and infectious diseases. Pharmaceutical companies conduct extensive research and clinical trials to create safe, effective drugs. This sector plays a crucial role in advancing global healthcare and combating diseases.
Expansion of Cross-Border E-Prescription Services Boosting Market Growth
The growing integration of digital health services and cross-border collaborations is driving the market. For instance, in September 2024, Estonia expanded its cross-border e-prescription service to include Lithuania and Latvia. This allows Estonian residents to easily obtain medications in Lithuanian pharmacies using their Estonian-issued e-prescriptions. The cross-border service will enhance patient access to essential medicines, supporting pharmaceutical market growth by improving accessibility, convenience, and efficiency in medication procurement across the Baltic region. This development is expected to positively impact Estonia's pharmaceutical market in the forecast period by increasing patient satisfaction and demand for e-prescription services.
Adoption of Advanced Technologies to Boost Estonia Pharmaceutical Market Value
The rapid growth of deep-tech companies and increased investment in biotechnology are key drivers for Estonia's pharmaceutical market. For instance, in November 2024, GeneCode, an Estonian pharmaceutical development company, joined the European Innovation Council’s Scaling Club. This membership will provide GeneCode with strategic mentorship, investment opportunities, and partnerships to advance its innovative drug development for neurodegenerative diseases. GeneCode’s rising prominence in biotechnology, particularly in treatments for conditions like Parkinson’s disease, strengthens Estonia's position in the global pharmaceutical landscape. The collaboration is expected to accelerate GeneCode's growth and further boost Estonia's pharmaceutical market, attracting investment and fostering innovation in the industry.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Molecules Type
Market Breakup by Type
Market Breakup by Sales Channel
Market Breakup by Indication
Market Breakup by Route of Administration
Market Breakup by Formulation
Market Breakup by Age Group
Market Breakup End User
Market Segmentation Based on Indication to Witness Growth
Based on indication, the infectious disease category is expected to hold a significant share in the Estonia pharmaceutical market due to the country's ongoing efforts to combat various infectious diseases, including bacterial, viral, and fungal infections. The increasing prevalence of infections, along with growing awareness and the adoption of advanced treatments, drives this segment's dominance. Additionally, government initiatives and collaborations with global pharmaceutical companies contribute to the continuous expansion of this category in Estonia's healthcare landscape.
Estonia's strategic location in Northern Europe enhances trade opportunities, while its focus on innovation fosters pharmaceutical research and development. Strong government support for healthcare initiatives and streamlined approval processes attract international investments. Additionally, Estonia's high adoption of technology ensures accessibility and cost-effective drug distribution, positioning the market as a leader in delivering modern, patient-centric pharmaceutical solutions.
The key features of the market report comprise patent analysis, clinical trials analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
AbbVie, founded in 2013 and headquartered in North Chicago, Illinois, focuses on immunology, oncology, neuroscience, and virology. It is known for its blockbuster drug, Humira, and continues to lead innovations in biologics and biosimilars.
Established in 1891 and headquartered in Kenilworth, New Jersey, Merck is a global leader in pharmaceuticals, ...
Headquartered in Basel, Switzerland, and founded in 1996, Novartis specialises in prescription medicines, part...
Pfizer, based in New York, was founded in 1849 and is a leading biopharmaceutical company. It is well-known fo...
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Sanofi SA, F. Hoffmann-La Roche AG, AstraZeneca plc, Eli Lilly and Company, and GSK plc.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Molecules Type |
|
| Breakup by Type |
|
| Breakup by Sales Channel |
|
| Breakup by Indication |
|
| Breakup by Route of Administration |
|
| Breakup by Formulation |
|
| Breakup by Age Group |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share